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Abstract
Background: Hyposalivation is caused by various syndromes, diabetes, drugs, inflammation, infection, or
radiotherapy of the salivary glands. Patients with hyposalivation often show an increased caries incidence.
Moreover, hyposalivation is frequently accompanied by oral discomfort and impaired oral functions, and saliva
substitutes are widely used to alleviate oral symptoms. However, preference of saliva substitutes due to taste,
handling, and relief of oral symptoms has been discussed controversially. Some of the marketed products have
shown demineralizing effects on dental hard tissues in vitro. This demineralizing potential is attributed to the
undersaturation with respect to calcium phosphates. Therefore, it is important to modify the mineralizing potential
of saliva substitutes to prevent carious lesions. Thus, the aim of the present study was to evaluate the effects of a
possible remineralizing saliva substitute (SN; modified Saliva natura) compared to a demineralizing one (G;
Glandosane) on mineral parameters of sound bovine dentin and enamel as well as on artificially demineralized
enamel specimens in situ. Moreover, oral well-being after use of each saliva substitute was recorded.
Methods/Design: Using a randomized, double-blind, crossover, phase II/III in situ trial, volunteers with
hyposalivation utilize removable dentures containing bovine specimens during the experimental period. The
volunteers are divided into two groups, and are required to apply both saliva substitutes for seven weeks each.
After both test periods, differences in mineral loss and lesion depth between values before and after exposure are
evaluated based on microradiographs. The oral well-being of the volunteers before and after therapy is determined
using questionnaires. With respect to the microradiographic analysis, equal mineral losses and lesion depths of
enamel and dentin specimens during treatment with SN and G, and no differences in patients’ experienced oral
comfort after SN compared to G usage are expected (H0).
Discussion: Up to now, 14 patients have been included in the study, and no reasons for early termination of the
trial have been identified. The design seems suitable for determining the effects of saliva substitutes on dental
hard tissues in situ, and should provide detailed information on the oral well-being after use of different saliva
substitutes in patients with hyposalivation.
Trial registration: ClinicalTrials.gov ID. NCT01165970
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Saliva is well recognized as an important factor in the
maintenance of oral health [1]. Hyposalivation is asso-
ciated not only with Sjögren’s syndrome or salivary
gland hypofunction in elderly patients, but also with the
use of medications that contain antimuscarinic drugs,
chemoradiotherapy for head and neck carcinomas, and
psychiatric disorders [2,3]. Moreover, various diseases
such as Riley-Day, Plummer-Vinson, and Heerfordt’s
disease can lead to hyposalivation [4-6]. Hyposalivation
can significantly increase the incidence of dental caries
[7], and might compromise the mucosal integrity, thus
resulting in oral pain [8]. Additionally, salivary dysfunc-
tion may result in a considerably worse morbidity, sleep
disturbances, difficulties in chewing and swallowing,
speech problems, loss of taste, and an increased inci-
dence of mucosal infections [9,10]. These adverse effects
can lead to predispositions of severe oral diseases and
nutritional deficiencies, and may result in an overall
decline in quality of life [11,12].
In particular, “radiation caries” (a non-appropriate, but
widely spread term), a rapidly developing and highly
destructive form of tooth decay, is a well-known conse-
quence of radiotherapy [7]. Radiation-induced hyposali-
vation is caused by functional changes in the salivary
glands. The most severe and irreversible forms of sali-
vary gland hypofunction result from damage to the sali-
vary acinar cells [13]. As secretion rates decrease, saliva
becomes more viscous [14], along with a more acidic
pH value [15]. These changes compromise the preven-
tive functions of saliva, and lead to a greater incidence
of caries after radiotherapy in the head and neck area
[9].
Artificial saliva has been shown to be efficacious in
relieving the subjective symptoms of hyposalivation [16],
and therefore, represents a well-accepted and important
treatment option. Several saliva substitutes, which differ
with respect to chemical compositions, thickeners or
viscosities, have been developed to lubricate and
moisten the oral mucosa. A previous study concluded
that artificial saliva containing mucin proved to be of
benefit to patients suffering from hyposalivation com-
pared to a carboxymethylcellulose (CMC)-based saliva
substitute due to a better improvement of the oral func-
tioning, a longer retention time on oral mucosae result-
ing in a lower amount of application needed per day
[17]. However, preference of different saliva substitutes
by various groups of patients has been discussed contro-
versially [16,18-21]. Up to now, clinical effects of the
polysaccharide-based saliva substitute Saliva natura (SN)
have not been documented. It might be speculated that
SN alleviates the orals symptoms of hyposalivation bet-
ter compared to the CMC-based solution due to a simi-
lar lubrication of the oral mucosa as mucins. In
consideration of the comparative pH of SN and Glando-
sane (G), the stimulating effect on resting salivation
should be nearly the same. Furthermore, compared to
the consumption of water or tea, the primary role of
these substitutes is to provide a prolonged moisturiza-
tion of the oral mucosa [7,22,23]. This property should
not be accompanied by any negative effects on dental
hard tissues (i.e., demineralization or erosion) or oral
health during the frequent use of saliva substitutes.
Previous in vitro studies revealed that some commer-
cially available saliva substitutes possess demineralizing
properties on enamel [24,25] and dentin [26]. Glando-
sane, a commercially available and widely spread saliva
substitute, is based on CMC, and has shown detrimental
demineralizing effects on enamel and dentin in vitro
[24-26]. In contrast, enhanced remineralization could be
observed after the addition of calcium, phosphates, and
fluorides to saliva substitutes. A modified version of Sal-
iva natura (a polysaccharide-based saliva substitute) that
is supersaturated with respect to octacalcium phosphate
(SOCP = 2) was capable of inducing enamel and dentin
remineralization in vitro [27,28]. However, hitherto no
clinical study has confirmed the numerous in vitro
results showing that saliva substitutes have de- or remi-
neralizing effects on dental hard tissues. Therefore, in
the current clinical trial, it is aimed to prove that the
use of SN is superior to G with respect to the mineraliz-
ing effects on dental hard tissues and that the patients
experience a better oral comfort while using SN com-
p a r e dt oG .C o r r e s p o n d i n g l y ,t h en u l lh y p o t h e s e sa r e
“no difference” between G and SN with respect to
mineral parameters and that there are “no differences”
in oral comfort while using SN compared to G.
Methods/Design
Experimental design and study population
This study is performed at the Department of Operative
Dentistry and Periodontology, University School of Den-
tal Medicine, CharitéCentrum 3, Charité - Universitäts-
medizin Berlin, Germany. A controlled, randomized,
crossover, double-blind, phase II/III in situ trial design
is conducted with volunteers who are residents of
Berlin. All participants are clinically evaluated by a
detailed dental examination and an unstimulated salivary
flow rate measurement. Before participating in the
study, volunteers are informed concerning the objec-
tives, benefits, and possible risks involved in the study.
The research team provides an informed consent form
that includes the study details, such as purpose, dura-
tion, required procedures, possible advantages, and key
contacts. The main inclusion criterion (Table 1) is an
unstimulated whole saliva flow of ≤ 0.1 ml/min. Further-
more, one removable dental prosthesis (upper or lower
denture) and an age over 18 years are required. Panelists
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the informed consent forms. The trial period is divided
into two phases, and each phase consists of seven weeks
with a washout period of seven days between the phases
(Figure 1). The volunteers are randomly allocated into
two groups. In each study leg, the participants are sub-
mitted to treatment with one of the two saliva substi-
tutes (Figures 1 and 2).
The randomization process was performed externally by
the Department of Biometry and Clinical Epidemiology
Table 1 Inclusion and exclusion criteria
Inclusion criteria Exclusion criteria
￿ Patients with oncologic diseases of the head and neck area, and
implemented radiotherapy of the head and neck area
￿ Men and women at the age of at least 18 years
￿ Unstimulated saliva flow rate < 0.1 ml/ min
￿ Patient’s education and written approval of the participation
before enrollment
￿ Good prognosis of life expectancy
￿ No paraben allergy
￿ Willingness to co-operate (compliance) of the patient
￿ Ability and willingness to return for follow-up visits
￿ No participation in other study (3 months before and) during the
participation
￿ Pregnancy and lactation period
￿ HIV-infection
￿ Hepatitis B/C virus infection
￿ Reluctance for the storage and disclosure of personal disease data in the
context of the study plan
￿ No written approval
￿ Paraben allergy
￿ Concurrent participation in another clinical study
￿ Persons who are accommodated on account of official or judicial
arrangement in an institution (§40 Abs.1 S.3 Nr.4 AMG)
￿ Patients who do not wear their dentures at night
￿ Known hypersensitivity to ingredients of Saliva natura and Glandosane
(sodium benzoate may cause slight irritation to skin, eyes, and mucous
membranes)
Figure 1 Study flow chart with presently ascertained patients’ figures.
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Page 3 of 12(CharitéCentrum 4, Berlin, Germany) using a computer-
generated random table (Microsoft Excel, Unters-
chleißheim, Germany). The investigators were not
involved in the randomization process, nor were they
aware of the assigned group in any of the outcome evalua-
tions. The identification codes for each panelist were
printed on the bottle labels at Charité’s pharmacy.
A dental study nurse is commissioned to allocate the
sealed envelopes, which contains the blinded saliva sub-
stitutes from the pharmacy. This procedure guarantees a
continuous medication blinding process for both pane-
lists and investigators. After each testing phase, all of
the released bottles are collected by the clinical investi-
gators to determine consumption based on weight. The
volunteers wear removable dentures comprising four
inserted specimens during each study phase (2 enamel
and 2 dentin specimens) (Figures 3 and 4d). All of the
specimens are obtained from one bovine tooth. Further-
more, the enamel specimens are divided into two sub-
groups, including sound and artificially demineralized
(subsurface lesion) enamel (Figures 3b, c and 4).
The patients are asked to perform individual oral
hygiene procedures using a fluoride-free toothpaste (Sal-
viagalen; Madaus, Cologne, Germany). In addition, they
are instructed to refrain from using any anti-caries or
anti-bacterial agents in addition to their oral hygiene
procedures which are continued on a regular basis.
Moreover, the participants are advised to avoid highly
fluoridated salts and foods.
Ethical considerations
The trial was approved by the Ethical Committee of
Berlin (Office State of Health and Social Affairs,
LaGeSo, Berlin, Germany) and by the German Federal
Institute for Drugs and Medical Devices (BfArM, Bonn,
Germany), and written consent was obtained from each
patient according to the current revision of the Helsinki
Declaration (originally adopted in June 1964, sixth revi-
sion in 2008). EudraCT (European Union Drug Regulat-
ing Authorities Clinical Trials) number 2008-005451-23
was assigned to the study by the European Medicines
Agency (EMEA, London, United Kingdom). The study is
registered under Clinical Trials database (Trial registra-
tion: ClinicalTrials.gov ID. NCT01165970). According to
valid German law, Glandosane is classified as a pharma-
ceutical drug, whereas Saliva natura represents a medical
device. Since both products are used, the present study
is considered a drug study.
Preparation of artificial salivas
Saliva natura (SN; medac, Germany) was modified by
the addition of calcium, phosphates, and fluorides
(Table 2), which resulted in a solution with an octacal-
cium phosphate saturation (SOCP)o f2 . 0a tab u f f e r e d
pH of 5.95 [27,28]. Glandosane (G; cell pharm, Hanover,
Germany), which represents a demineralizing saliva sub-
stitute, was tested in its pure form (original drug).
Specimen preparation and lesion formation
One hundred and fifty-five permanent bovine central
and lateral incisors were obtained from newly slaugh-
tered cattle (Figure 4a). The bulk of the adherent soft
tissues was carefully removed using scalpels (disposable
scalpel; Feather, Osaka, Japan), and the teeth were
stored in 0.9% sodium chloride solution until further
processing (Fresenius; Bad Homburg, Germany). Two
Figure 2 Study design. t0: - Integration of specimens into removable (partial) dentures Covering of reference areas/sound surfaces of
specimens - Issue of study medication (blinded) - Anamnesis and oral findings - Measurement of unstimulated saliva flow rate - First
questionnaire. t5: - Covering of effect areas after five weeks - Measurement of unstimulated whole saliva. t7: - Removal of specimens from the
dentures - Measurement of unstimulated saliva flowrate - Second questionnaire - Collecting of spray bottles. t8: - Integration of specimens into
the removable (partial) dentures - Covering of the reference areas/sound surfaces of specimens - Issue of study medication (blinded) -
Anamnesis and oral findings - Measurement of unstimulated saliva flowrate - Third questionnaire. t13: - Covering of effect fields after five weeks -
Measurement of unstimulated saliva flowrate. t15: - Removal of specimens from dentures; repair of dentures - Measurement of unstimulated
saliva flowrate - Last questionnaire - Collecting of spray bottles.
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³) were prepared from
the labial aspect of each crown under running tap water
using a diamond-coated band saw (Exakt 300cl; EXAKT
Apparatebau, Norderstedt, Germany). Two dentin speci-
mens were prepared from the cervical regions: one spe-
cimen from the oral and one from the buccal aspect
(Figure 4a). Enamel and dentin surfaces were ground
flat and polished progressively up to 4,000 grit (silicon
carbide abrasive paper; Hermes, Hamburg, Germany;
Figure 4a). The surfaces were examined under a stereo-
microscope (Axioplan 2; Carl Zeiss, Göttingen, Germany)
with a magnification factor of 10 to ensure absence of
any defects or physical damage. One enamel specimen
from each incisor was then embedded in epoxy resin
(Technovit 4071; Heraeus Kulzer, Wehrheim, Germany;
Figure 4b), while the natural surface was kept free from
resin. The flat parts of the specimens were ground and
polished up to 4,000 grit (silicon carbide; Struers,
Ballerup, Denmark), thereby removing the outer parts of
the enamel (approximately 200 μm).
Artificial subsurface lesions were created in half of the
enamel specimens (Figure 4b) as described previously
[29]. In addition, one quarter of the surface of each spe-
cimen was covered with acid-resistant nail varnish (Jet-
Set; L’Oréal, Paris, France) to serve as control for sound
enamel (Figure 4b). Enamel subsurface lesions were pre-
pared by immersion in 5 liters of a solution containing
6 μMM H D P ,3m MC a C l 2 ×2H 2O, 3 mM KH2PO4,
and 50 mM CH3COOH (Merck, Darmstadt, Germany)
at a pH of 4.95 in an incubator (37°C; BR 6000; Heraeus
Kulzer, Hanau, Germany) for 19 days. The pH value
was monitored daily (pH electrode GE 100 BNC, con-
nected to pH meter GMH 3510; Greisinger, Regenstauf,
Germany), and slight elevations were corrected by the
addition of small amounts of HCl to maintain constant
pH values between 4.92 and 4.98 during the deminerali-
zation period. Standard buffer solutions (Sigma-Aldrich,
Steinheim, Germany) with nominal pH values of 4.0 and
7.0 and an accuracy of 0.01 units were used to calibrate
the pH meter. All specimens (enamel, demineralized
enamel, and dentin) were then sterilized with cold gas
(ethylene oxide; 55°C for 30 minutes; German Heart
Institute Berlin, Germany), and were vented for eight
hours [30].
Experimental phase
Two dentin and two enamel (one sound and one artifi-
cially demineralized enamel specimen) specimens were
inserted into every buccal aspect of each removable den-
ture (Figures 3a and 4d). The specimens were positioned
in the regions from the second premolar to the second
molar (Figure 3a). Resinated wax (Supradent; Opper-
mann-Schwendler, Bonn, Germany) was used to fix the
specimens into manually prepared cavities at the buccal
Figure 3 Arrangement of specimens in the prosthesis and various test fields of both hard tissues. a: - Lower removable full denture with
inserted specimens (mesial two dentin specimens, distal two enamel specimens). b: - Arrangement of artificially demineralized enamel
specimens (S: sound surface as reference; D: artificially demineralized surface as reference; E1: effect on the artificially demineralized surface after
five weeks; E2: effect on the artificially demineralized surface after seven weeks). c: - Arrangement of sound enamel specimens (E1: effect on
sound surface after five weeks; E2: effect after seven weeks). d: - Arrangement of sound dentin specimens (E1: effect on sound surfaces after five
weeks; E2: effect after seven weeks).
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not intended to be exposed to the oral environment
(serving as control) was covered with acid-resistant nail
varnish (Jet-Set) and flowable composite (Tetric Evo-
Flow; Ivoclar Vivadent, Ellwangen, Germany; Figure 3).
The sound specimens’ surfaces were divided into three
parts: control (sound/no exposure), effect 1 (effect after
five weeks of in situ exposure), and effect 2 (effect after
seven weeks of in situ exposure; Figure 3c, d). The artifi-
cially demineralized enamel specimens comprised two
control areas (sound and artificial demineralization;
Figure 3b). After each exposure, the specimens were
carefully removed and stored in saline solution (sodium
chloride, 0.9%; Fresenius) until further evaluation.
Investigation of the salivary flow rate
Unstimulated salivary flow rate of the patients was
determined at each visit. All patients collected their sal-
iva over a period of five minutes during which they
were sitting upright and spat into a measuring cup,
Figure 4 Study procedure and experimental set-up. a: - Specimen preparation from permanent bovine incisors - Enamel and dentin surfaces
ground flat and polished. b: - Artificial lesion creation in half of the enamel specimens. c: - Sterilization (ethylene oxide) of all specimens (enamel
and dentin). d: - Insertion of four specimens into removable dentures during each phase (2 enamel specimens and 2 dentin specimens) -
Blinded medication and fluoride-free toothpaste. e: - Preparation of thin sections (100 μm). f: - Microradiographic analysis of thin sections and
statistical analysis.
Table 2 Composition of the study medication and calculated saturations with respect to calcium phosphates and CaF2
calculated saturation of an aqueous solution with respect to: pH ion concentrations (mM)
solution DCPD OCP HA CaF2 Ca PO4 F K Cl Na Mg
Glandosane 0.2 0.3 0.9 – 5.3 1.0 2.6 0 19.0 33.8 14.8 0.3
mod. Saliva natura 1.3 2.0 7.1 0.6 5.98 3.2 5.0 0.1 6.7 6.3 0 0
Abbreviations: DCPD (dicalcium phosphate dihydrate), OCP (octacalcium phosphate),
HA (hydroxyapatite), CaF2 (calcium fluoride).
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was calculated. Previous smoking or mastication was
waived, and the measurements were performed as
described previously [30].
Questionnaire
Patient characteristics such as age and sex were
recorded. The patients were questioned about the fre-
quency of saliva substitute use and the perceived persis-
tence of the substitute in the oral cavity. The remaining
amount of saliva substitute was collected and weighed
to evaluate consumption. All of the questions concern-
ing hyposalivation and quality of life were answered
using the German school mark scale (1-6; 1 = very
good, 6 = poor), which was familiar to the patients.
Questionnaires referenced to a previous trial [16] and to
surveys from the European Organization for Research
and Treatment of Cancer (EORTC) QOQ-C33 and the
EORTC Head and Neck (H&N35) [31]. The subjects
responded to these questionnaires at six time intervals:
prior to participation as well as after 5, 7, 8, 13, and
15 weeks.
Microradiographic analysis
After in situ exposure, all of the specimens were
mounted on transparent plexiglass microscopic slides
(plexiglass-microscope slide; dia-plus, Oststeinbek, Ger-
many) and cut into 300-μm-thick sections (perpendicular
to their surfaces). These slices were ground (1,200, 2,400,
4,000 grit; Exakt) to achieve plane parallelism (Figure 4e)
on wet abrasive paper (Hermes) until the remaining
thickness of each slice was approximately 100 μm (± 10;
Figure 4e). The width of the parallel specimens was veri-
fied using a digital micrometer with a precision of 1 μm
(outside micrometer Digimatic; Mitutoyo, Kawasaki,
Japan). Contact microradiographs of the enamel and den-
tin specimens were obtained using a nickel-filtered cop-
per (CuKa) X-ray source (PW 1830/40; Philips, Kassel,
Germany) operating at 20 kV and 10 mA for dentin as
well as 20 kV and 20 mA for enamel. The exposure time
for enamel and dentin was 5 seconds. During the radio-
graphic procedures, the dentin specimens were treated
with ethylene glycol (99%; Sigma-Aldrich, Munich, Ger-
many) to avoid shrinkage [32]. An aluminum step wedge
was used to generate all of the microradiographs. The
radiation source-to-film distance was 34 cm. A high-
resolution film (motion picture fine grain positive film
71337; Fujifilm, Tokyo, Japan) was used and developed
under standardized conditions according to the manufac-
turer’s recommendations.
The microradiographs were studied using a digital
image-analyzing system (CCD video camera modul
XC77E; Sony, Tokyo, Japan) interfaced with a micro-
scope (Axioplan; Zeiss, Oberkochen, Germany) and a
personal computer (ASUS P4P800X; ASUS, Taipei,
Republic of China in Taiwan). Mineral loss (vol% × μm)
was calculated by integrating the difference between the
mineral content (vol%) in sound and demineralized
enamel and dentin over the depth of the mineral lesion
(μm). For all specimens, the lesion depth was defined as
the distance from the surface to the location in the
lesion where the mineral content was greater than 95%
of the mineral content of sound enamel or dentin. The
mineral volume percentage of sound enamel was set at
87% of the total volume, and that of sound dentin was
set at 50% (TMR for Windows 2.0.27.2; Inspektor
Research Systems, Amsterdam, The Netherlands).
If one specimen demonstrated surface erosions after
in situ exposure, an adjacent sound part of the specimen
was used for microradiography to permit adjustment of
the starting point. Mineral loss and lesion depth at the
specimens’ surfaces were determined separately for each
test field (Figure 3). Mineral losses in sound areas
(ΔZSound; S in Figure 3) were subtracted from the
respective values determined for artificially deminera-
lized areas (ΔZDemin; D in Figure 3b) and from the areas
that were exposed to saliva substitutes for either five
(ΔZEffect 1) or seven weeks (ΔZEffect 2) [33,34]. In artifi-
cially demineralized specimens, the values of the demi-
neralized fields were subtracted from those obtained for
the particular effect fields (E1 and E2 in Figure 3).
Changes in mineral loss (ΔΔZEffect 1 = ΔZDemin - ΔZEffect 1;
ΔΔZEffect 2 = ΔZDemin - ΔZEffect 2) were also determined.
Positive and negative ΔΔZ values indicated remineraliza-
tion and demineralization, respectively. Lesion depths
were determined using analogous methods.
Statistical analyses
Sample size was calculated using nQuery (version 3.0;
Statistical Solutions, Cork, Ireland) prior to the start of
this in situ study. To determine an appropriate speci-
men quantity to achieve an adequate power of 80% and
a defined significance level of 5% (p < 0.05), the number
of participants was determined to be 38 (in anticipation
of a dropout rate of 10%). The expected mean value of
mineral loss was 200 vol% × μm with a standard devia-
tion of 400 vol% × μm. These values were calculated
taking into account the ascertained values of previous
in vitro studies [27,33]. In detail, those studies gave
informations about the required contact time between
specimens surface and saliva substitute in vitro, thus
these results served as base for determining the speci-
mens in situ contact time storage. After transversal
microradiography evaluation and collection of the ques-
tionnaires, statistical analyses will be conducted using a
t-test for paired samples. In the case of non-normally
distributed values, we will apply Wilcoxon’ss i g n e d - r a n k
test. Commercially available software (PASW for
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used for all statistical computing.
Results
Hitherto, 14 patients with oral dryness who reside in
Berlin have been recruited for the present study. These
patients completed both test phases (Figure 1). Up to
now, no reasons for early termination of the trial have
been identified. Therefore, evaluation of the data will be
performed after recruitment of the last participant. For
this reason patient/specimen allocation will remain
blinded.
Discussion
Hyposalivation is mostly associated with various syn-
dromes, diabetes, vitamin deficiency, menopause, sali-
vary gland hypofunction due to inflammation, infection,
the use of various drugs, or radiotherapy. Since inci-
dence of head-and-neck cancer [35] and amount of drug
revenue increases with age, primarily older patients suf-
fer from hyposalivation [36]. Furthermore, periodontal
diseases occur predominantly in elderly patients and
often lead to gingival recessions [37]. Additionally, pro-
gressive attrition/abrasion during prolonged utilization
of the teeth causes dentin exposure [38]. Since dentin is
not as resistant as enamel to acid exposure, earlier and
more severe demineralization can be expected [39].
Thus, carious lesions located at the cervix of the teeth
develop easily during radiation therapy [40,41]. There-
fore, in the present study, both enamel and dentin were
assessed.
T h et e e t hu s e di nt h ep r e s e n ts t u d yw e r eo b t a i n e d
from newly slaughtered cattle. One of the major disad-
vantages of human teeth compared to bovine teeth is
the occurrence of defects such as initial carious lesions.
It can be assumed that bovine teeth are rarely influ-
enced by external factors (e.g., acids, fluorides), and,
thus, the biological spread of bovine teeth is relatively
small [25,42]. In contrast, human teeth usually exhibit
an inconsistent age and source, which might result in a
variable composition that leads to larger variations in
the test response. Due to their similar chemical compo-
sition, general availability and large size, bovine teeth
are a suitable substitute for human dental hard tissues
in in situ examinations, and a more uniform reaction
can be expected using these specimens [42]. Moreover,
lesion formation in bovine enamel is very similar to the
demineralization process observed in human enamel
[25]. However, bovine enamel is generally considered a
more porous material compared to human enamel, and,
thus, bovine enamel may be susceptible to accelerated
demineralization [43]. For in situ studies into caries pre-
vention, sterilization of tooth specimens is essential.
Sterilization of enamel and dentin using ethylene oxide
has not been considered to induce relevant effects with
in situ studies of de- and remineralization [44].
As a precursor of dental caries, initial subsurface
lesions appear in many patients [1]. These lesions were
simulated in the present study by the artificial deminera-
lization (i.e., subsurface lesion) of half of the enamel
specimens before in situ incorporation. Furthermore, an
investigation of the remineralization processes requires
the utilization of artificially demineralized enamel speci-
mens that are adjacent to sound specimens. Due to the
possibility of disintegration during the in situ exposure,
the dentin specimens were not artificially demineralized.
Four specimens that were obtained from one bovine
tooth were embedded into the removable denture of
one patient during each experimental phase (Figures 3a
and 4). This procedure ensured that the specimens from
one tooth were only used for one patient and that one
bovine individual-to-one patient regimen was main-
tained. Furthermore, the enamel and dentin specimens
correlated with respect to their source during each test
phase, and this permitted a comparison of the in situ
effects of demineralization and remineralization between
dentin and enamel.
To investigate the effects of the study medication on
the specimen surfaces after a wearing period of five and
seven weeks, the surfaces were divided as described
(Figure 3). By covering the respective surface areas with
acid-resistant nail varnish and a flowable composite, the
sound and artificially demineralized regions were main-
tained during the entire in situ investigation for the
microradiographic analyses. Additionally, the coverage
of the effect fields (E1; Figure 3) after five weeks ensured
that this surface areas were not affected by additional
de- and remineralizing effects. This method allowed the
determination of distinguishable test areas.
Specimens attached on natural teeth could interfere
with mastication and articulation, and, therefore, speci-
mens were fixed in removable dentures. However, it has
to be taken into account that wearing a dental prosthe-
sis (full or partial) can significantly affect the composi-
tion of the resident oral microflora, and, following, the
results might be influenced by this factor [45]. There-
fore, this factor should be kept in mind when interpret-
ing the upcoming data. Unlike former in vitro studies
[46], the coverage areas were additionally fixed with
flowable composite to ensure the ability to withstand
mechanical forces during the study period. Up to now
no visible gaps between the specimen surfaces and the
coverings have been recognized. Moreover, the addi-
tional test field coverage with composite resin seems to
be advantageous for protection of surface areas. So far
no coverage losses could be observed.
The intention of the chosen in situ model was to
mimic the natural caries process and provide clinically
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without causing irreversible tissue changes in the pane-
lists’ dentition. Generally, clinical caries trials are limited
to investigations by a dental explorer, and to using
radiographs to identify and validate demineralizations at
sites usually not visible directly. Thus, the caries process
is determined at a relatively late stage and patients are
exposed to X-rays resulting in an increasing radiation
exposure. In contrast, the in situ model presented here
offers the integration of transversal microradiography
(TMR) as a basic science analytical technique. TMR
offers high sensitivity and ensures waiving radiation
exposure for panelists [47]. Generally, various experimen-
tal methods are available for analyzing subsurface lesions
of bovine enamel and dentin specimens. These include
transversal microradiography [48], polarized microscopy
[49], microhardness testing [50,51], electric caries
monitoring [52], transversal wavelength-independent
microradiography [53], optical coherence tomography
[54], and scanning electron microscopy [55,56]. With the
exception of transversal microradiography (TMR), all
mentioned technologies reveal some shortcomings with
regard to accuracy when specimens are analyzed accord-
ing to the mentioned parameters mineral loss and lesion
depth. In contrast, TMR allows a direct measurement of
the longitudinal mineral distribution as a profile in a
subsurface lesion and has long been established and
recognized as a gold standard for analyzing mineral
content changes over time [57]. Consequently, TMR is
considered a surrogate outcome measure that is directly
impacted by the intervention. Thus, microradiographic
outcome was selected as a surrogate endpoint in the
present study.
Since fluorides are commonly found in foodstuff such
as salt, fish, and mineral water, the study implementa-
tion required a renunciation of several foods in terms of
a fluoride-free diet. This adjustment was only estab-
lished for the (short) in situ p e r i o d ,a n dt h u s ,m i g h t
represent a lower personal burden for the patients com-
pared with long-term clinical trials [47]. Altogether, an
in situ model might better conform with the patients’
requirements, and these always have to be weighed
against the background of protracted cancer-related
therapies.
Saliva substitutes such as the widespread Glandosane,
which contains acids and a relatively low amount of cal-
cium and phosphates (and, therefore, is undersaturated
with respect to calcium phosphates), have demonstrated
demineralizing properties in vitro [1,25,26,33]. From the
perspective of dental medicine, neutral or even reminer-
alizing effects of artificial salivas would seem preferable
[48]. Glandosane has a pH value of 5.3, whereas the pH
value of the modified SN is approximately 5.98. Due to
the strict permission criteria for the modification of
existing saliva substitutes (German Act of Medical
Devices), a higher pH value could not be adjusted for
SN. Even solutions with low pH values or a large
amount of titratable acids do not cause demineralization
in dental hard tissues, if an appropriate saturation is
used with respect to relevant calcium phosphates via a
reduction of the apatite solubility [58]. In previous
in vitro studies, supersaturated solutions such as modi-
fied SN was observed to remineralize enamel and dentin
over a period of five weeks, and this has been attributed
to the addition of calcium, phosphates and fluorides
[33]. Human saliva can be considered a supersaturated
solution with respect to hydroxyapatite (HA), and has a
mean pH value of 6.7 under physiological conditions
[1]. In addition to flushing purposes, saliva also acts as a
buffer. Bicarbonate and phosphate buffers in particular
allow for neutralization of organic acids via diffusion
through the dental plaque. The saliva of patients who
suffer from hyposalivation after radiotherapy reveals a
decreased pH value (i.e., acidic pH value), which pro-
motes the demineralizing processes of dental hard
tissues.
The primary component of enamel is HA. The solubi-
lity of a substance is characterized by its solubility pro-
duct (K). For a solution such as saliva, the ion product
(IP) is based mainly on the calcium, phosphate, and
hydroxyl concentrations. The thermodynamic driving
force of enamel de- or remineralization is a function of
the degree of saturation with respect to HA (DSHA)
[59,60], and the degree of saturation of a solution (DS)
can be defined by dividing the product of the ion activ-
ities (IP) by K, and exposing this result to the number
of ions in the formula unit [61]. If DS is greater than 1,
the solution is supersaturated with respect to the calcu-
lated mineral phase; if DS is less than 1, the solution is
undersaturated; in case of DS equals to 1, the solution is
saturated, and no net dissolution or precipitation occurs.
For aqueous solutions, the degree of saturation with
respect to apatites [HA, octacalcium phosphate (OCP),
dicalcium phosphate dihydrate (DCPD), and calcium
fluoride (CaF2)] can be calculated, if the pH and the
concentrations of certain ions are known [62]. In a pre-
vious study [27] that determined the composition of the
SN used in the present one, IONPRODUCT, which was
developed by Peter Shellis [62], was used. IONPRO-
DUCT is a computer program that calculates the ionic
activity of products and the degree of solution saturation
with respect to biologically relevant calcium phosphates.
The input values are the concentrations of the constitu-
ent ions, pH, temperature, and atmospheric pressure.
A database contains the required solubility products of
each of the minerals and the relevant dissociation con-
stants. The program can be used to determine the DS at
different pH values for a given calcium concentration.
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substitutes is higher compared to products with neutral
pH values, the current pH values of SN as well as of G
might support patient compliance [27,33]. In the present
study, an experimental period of seven weeks was
selected. The present test field design refers to former
in vitro studies exhibiting effects after an investigation
of five weeks [33,48,63]. Since artificial saliva was clini-
cally administered ad libitum, no maximum daily dose
could be assumed. These procedures, employed in pre-
vious in vitro studies, simulated an extremely intense
contact between saliva substitutes and specimens during
an experimental time of up to five weeks, and, hitherto,
these conditions could not be replicated with clinical
settings and conditions. Therefore, in comparison to for-
mer in vitro studies a longer examination time of seven
weeks was selected.
It is important to note that unlike the conditions
observed in vitro, a total absence of saliva is rarely
observed in clinical situations. Due to a variable pre-
sence of saliva, compositional changes [15], and the
decreased pH values detected in the present in situ
study, slightly altered results should be considered.
Despite the omission of factors such as nutrition, pre-
vious studies have noted the development of erosions
on the specimen surface even under strictly controlled
in vitro conditions. Variability in patient diets, especially
the consumption of sour drinks/food, might lead to the
development of erosion. To reduce the influence of diet
on mineralization, the patients were provided with
nutritional counseling. In the present study, the patients
were asked to restrain from the consumption of any
sour foodstuffs during the test period to avoid any bias.
Furthermore, panelists’ were asked to abstain from any
additional intake of fluorides from food or any form of
fluoride-containing oral hygiene products. Therefore,
advisory information and nutrition counseling regarding
fluoride uptake was conducted for all patients to illus-
trate the need of a fluoride-free diet. In particular, the
panelists’ were required to abstain from fluoride-con-
taining toothpaste; instead, fluoride-free toothpaste was
administered.
To receive the patients’ personal assessment concern-
ing their well-being and usage of salivary substitutes,
questionnaires were handed out as described before
(Figure 2). The simplicity of the questionnaires which
was enabled by referring to the German school mark
scale (1-6; 1 = very good, 6 = poor), being familiar to
the patients, allowed for straightforward answers to the
questions and provided a fast and simple evaluation by
the investigators. The evaluated personal well-being and
the self-assessed intensity of dry mouth before and after
the use of each saliva substitute can be compared with
each other and with the collected data containing
measured values of the amount of natural salivation and
saliva substitutes consumption during each trial. In
addition, the questionnaires provide important informa-
tion on the general acceptance of the use of saliva sub-
stitutes in terms of taste and duration.
Optimal oral hygiene and regular oral screening is
necessary in individuals with hyposalivation due to an
increased risk for caries and periodontal diseases. Saliva
substitutes should not only relieve the symptoms of oral
dryness, but should also provide protection against
demineralization. In addition to other in situ studies
investigating caries formation and the protective effect
of fluorides, the present study is the first clinical trial to
evaluate the effects of saliva substitutes on dental hard
tissues in situ. It is difficult to control human behavior,
and, therefore, the data which will be obtained herein
m i g h td i f f e rf r o mt h o s eg e n e r a t e di np r e v i o u sin vitro
studies. Despite these considerations, the present study
has the potential to provide clinical data that can
improve the effects of salivary substitutes and their
acceptance among patients. Thus, the results of the pre-
sent study should be important for future treatment
guidelines for patients suffering from hyposalivation.
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